6 Analysts Have This to Say About Silk Road Medical
Portfolio Pulse from Benzinga Insights
In the last quarter, Silk Road Medical (NASDAQ:SILK) received 4 bullish, 1 indifferent, and 1 somewhat bearish rating from analysts. The average 12-month price target for the company is $44.33, a decrease of 19.88% from the previous average of $55.33.
July 11, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Silk Road Medical received mostly bullish ratings from analysts, but the decrease in the average price target could indicate a potential short-term downward pressure on the stock.
The majority of analysts gave Silk Road Medical a bullish rating, indicating a positive outlook. However, the decrease in the average price target suggests that analysts may be adjusting their expectations downwards, which could potentially lead to a short-term decrease in the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100